MRNA Jun 2023 220.000 call
| Previous close | 1.1800 |
| Open | 0.9800 |
| Bid | 0.5500 |
| Ask | 0.8800 |
| Strike | 220.00 |
| Expiry date | 2023-06-16 |
| Day's range | 0.9800 - 0.9800 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.57k |
- Motley Fool
Could CRISPR Therapeutics Become the Next Moderna?
CRISPR Therapeutics (NASDAQ: CRSP) has a couple of things in common with a company that's made the headlines over the past few years: coronavirus vaccine maker Moderna (NASDAQ: MRNA). Today, CRISPR's market value sits at about $3.4 billion. Since, Moderna has grown to become a $58 billion company, with a blockbuster product and three more potential ones on the horizon.
- Motley Fool
3 Things About Moderna That Smart Investors Know
Moderna (NASDAQ: MRNA) helped some investors make a fortune over the past few years. The stock has climbed more than 400% since March 2020 -- that's when the company's coronavirus vaccine program gained traction. Recently, though, investors have worried about Moderna's post-pandemic revenue, and that's weighed on share performance.
- Zacks
Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio
Moderna (MRNA) collaborates with Generation Bio to develop non-viral genetic medicines. For this, it leverages the latter's closed-end DNA (ceDNA) and cell-targeted LNPs (ctLNP) technologies.
